This module discusses the common barriers to the initiation and intensification of insulin therapy, and the efficacy exhibited by next-generation long-acting analogues, like Gla-300 in establishing glycaemic control in patients with diabetes.
This module is based on a CPD symposium delivered by Professor Kamlesh Khunti.
You must be a member to access this content.
To become a member, please register here.
If you're already a member, please sign in to access.